MedPath

Comparing the effects of levetiracetam and phenytoin in the treatment of neonatal seizures

Phase 3
Conditions
Convulsions of newborn
eonatal seizure.
Registration Number
IRCT20220619055221N1
Lead Sponsor
rmia University of Medical Sciences Research Vice President
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
60
Inclusion Criteria

neonate with seizure
term neonate up to 28 days
preterm neonate up to 44 weeks of gestational age

Exclusion Criteria

neonate without seizure

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy of phenytoin and levetiracetam in the treatment of neonatal seizures. Timepoint: The first 24 hours after the drug. Method of measurement: No recurrence of seizures in the first 24 hours after the drug.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath